MEXICAN CONSENSUS ON THE DIAGNOSIS AND MANAGEMENT OF HEPATITIS C INFECTION
Journal Title: Annals of Hepatology - Year 2015, Vol 14, Issue 1
Abstract
Authors and Affiliations
Juan Sánchez-Ávila, Margarita Dehesa-Violante, Nahum Méndez-Sánchez, Francisco Bosques-Padilla , Mauricio Castillo-Barradas , Graciela Castro-Narro , Laura Cisneros-Garza , Ruby Ann Chirino-Sprung, Ignacio García-Juarez , Ma. Saraí Gonzalez-Huezo , René Malé-Velazquez , Rosalba Moreno-Alcántar , Linda Muñoz-Espinoza , Mayra Ramos-Gómez , Ma. Teresa Rizo-Robles , Ricardo Sandoval-Salas , Juan Sierra-Madero , María del Rocío Torres-Ibarra , Rodrigo Vazquez-Frias , Enrique Wolpert-Barraza
Prevalence of hepatitis C virus infection among patients undergoing haemodialysis in Latin America
Hepatitis C infection is a worldwide problem. The global prevalence of the hepatitis C virus (HCV) averages 3%. Moreover, its prevalence among patients undergoing haemodialysis (HD) varies worldwide, ranging from as low...
The use of sildenafil to treat portopulmonary hypertension prior to liver transplantation
Portopulmonary hypertension (PPH) is an infrequent, but well-recognized complication of liver cirrhosis. PPH in those with end-stage liver disease has a significant impact on per-operative and intra-operative mortality,...
Evidence-Based Medicine and the Problem of Healthy Volunteers
Healthy controls are subjects without the disease being studied but may have other conditions indirectly affecting outcome. In the present epidemics of obesity a few subjects with undiagnosed nonalcoholic fatty liver dis...
Is ursodeoxycholic acid detrimental in obstructive cholestasis? A propos of a case of malignant biliary obstruction
Ursodeoxycholic acid (UDCA) is the first choice medication for most cholestatic hepatopathies, due to its capability to counteract inflammation and bile-acid-induced liver damage, two common features in cholestasis. How...
Indications for treatment in chronic HCV infection
HCV Infection is a global burden disease and it is related to the development of progressive liver fibrosis, cirrhosis and hepatocellular carcinoma. At least 80% of the persons that have an acute infection evolve to chro...